
Oyster muscle (Crassostrea talienwhanensis) was purchased from a local market (Hainan, China). They were kept in cold seawater and transported to the laboratory. After rinsed, the whole fresh muscle was homogenized by speed tissue homogenizer. The homogenates were transferred into beakers, sealed and stored at -20°C until used for enzymatic hydrolysis. Ficin was supplied by Henan Biological Engineering Technology Co. (Henan, China). Flavorzyme was provided by Jiangsu Biotechnology Co. (Jiangsu, China). 2,2-azino-bis(3- ethylbenzthiazoline)-6-sulfonicacid (ABTS) and 1,1-Diphenyl-2-picrylhydrazyl (DPPH) were obtained from Shanghai Yuanye Biotechnology Co. (Shanghai, China). All other chemicals and solvents used in the experiments were of analytical grade.
According to our previous study, the oyster muscle was hydrolyzed by double proteases including ficin and flavourzyme. Briefly, a certain amount of homogenate was taken into a beaker and mixed with distilled water. The proportion of homogenate and distilled water was 1:2 (g/mL) and the amount of proteases was 12% (the proportion of ficin and flavourzyme was 3:1). After adjusting to a required pH 6.0 by addition of 1 M NaOH or 1 M HCl, the mixture was incubated at temperature of 50°C for 3 h, with continuously stirring. After hydrolysis, the homogenate was boiled for 10 min to inactivate proteases, and then cooling it immediately in a water bath to room temperature. The homogenate was centrifuged at 4000g for 20 min to remove any insoluble residues. The supernatants containing water-soluble hydrolysates were collected. The oyster enzymatic hydrolysates were lyophilized and stored at −20°C for further use.
The oyster muscle (1g) was digested with 10mL 6 M HCl at 110 ± 1°C under a vacuum for 22 h, using qualitative filter paper to filter the hydrolyzed oyster muscle, and then adjusted to pH 8.0. While the oyster enzymatic hydrolysates (20 mL) were mixed with 20 mL of 5-sulphosalicylic acid solution (10%, w/w) at 4°C for 17 h. After that, the solution was filtered by qualitative filter paper and then adjusted pH to 8.0. Amino acids of oyster enzymatic hydrolysates and oyster muscle were quantified by reverse phase high-performance liquid chromatography (RP-HPLC) on a AccQ-Tag amino acid analysis column (15 cm length × 3.9 mm i.d., Waters) coupled with a 2695- 2475 system (Waters Corporation, Milford, MA) were detected at 248 nm, 37°C. The samples were then eluted with two solvents (A: 10% acetate- phosphate buffer solution in ultrapure water, B: 60% aceto-nitrile in ultrapure water) at a flow rate of 1.0 mL/min. Amino acids were detected by a UV detector at 220 nm. The amounts of amino acids were calculated by comparing the peak area with standards [6].
The ether soluble volatile flavor components in oyster enzymatic hydrolysates (10 ml) were extracted with 15 ml of aether by intermittent extraction 60 min (each ultrasonic 15min, 5min), using ultrasonic oscillator. The organic extracts were dehydrated over anhydrous magnesium sulphate for 12h, and then dried the aether to obtain a final sample of 0.2 ml. Qualitative and quantitative identification of volatile flavor components were analyzed by a HP 6890N gas chromatography-5973 mass selective detector (GC-MS) (Hewleft-Packard, Palo Alto, CA, USA) equipped with a DB-5MS capillary column (30m length × 0.25 mm i.d., Agilent). Helium was the carrier gas at settled flow rate of 0.3 ml/min, no split. The GC oven temperature was initially at 40OC for 2 min, and ramped at 5°C /min to 60°C, then raised to 100°C at a rate of 3°C /min, post run at 18°C /min, 240°C for 6 min at last. Injector and detection temperature were 250°C and 240°C, respectively. The electron-impact (EI) mass spectra were generated at 70 eV, an ion source temperature of 200°C with m/z scanning range from 20 to 500 amu. For mass spectrum (MS), tentative identifications were compared with those in the NIST98 MS database.
Scavenging activity on 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical
The DPPH radical scavenging activity was measured according to the procedure described by Wu [7] with a slight modification. Briefly, 2.0 mL DPPH-ethanol solution (0.2 mM) was mixed with 2.0 mL of the oyster enzymatic hydrolysates. After vortex, the reaction mixture was kept in dark at room temperature for 30 min and then the absorbance of reaction mixture was measured at 517 nm. The DPPH radical scavenging activity was expressed as: scavenging rate (%) = [1–(Ai–Aj)/A0]×100, where Ai is the absorbance of the reaction solution, Aj is the absorbance of the solution including 2.0mL of ethanol and 2.0 mL of the oyster enzymatic hydrolysates, A0 is the absorbance of the solution including 2.0 mL of DPPH-ethanol solution (0.2 mM) and 2.0 mL of distilled water. And 2.0 mL of ethanol with equal volume distilled water as blank zero. The IC50 value was defined as the concentration of sample (mg/mL) required to scavenge 50% of DPPH radical. Ascorbic acid was used as a positive control. All experiments were carried out in triplicate.
The scavenging effect of the oyster enzymatic hydrolysates on hydroxyl radical was conducted in accordance with the method of Wang [8] with a slight modification. Briefly, the reaction fluid mixed with 1mL of 2-hydroxybenzoic acid (9 mM), 1mL of ferrous sulphate (9 mM), 1mL of hydrogen peroxide (10 mM) and 1 mL of oyster enzymatic hydrolysates with various concentrations. Following incubation at 37°C for 30 min, the absorbance of the mixture was measured at 510 nm. The hydroxyl radical scavenging activity was expressed as: scavenging rate(%)= [1–(A1–A2) ⁄ A0]×100, where A1 is the absorbance of the reaction solution, A2 is the absorbance of the solution including 2.0 mL of ethanol and 2.0 mL of oyster enzymatic hydrolysates A0 is the absorbance of reaction solution mixture with oyster enzymatic hydrolysates replaced by equivalent volume of distilled water. Ascorbic acid was used as a positive control. All experiments were carried out in triplicate. The IC50 value was defined as the concentration of sample (mg/mL) required to scavenge 50% of hydroxyl radical.
ABTS radical scavenging activity was determined according to the modified method of Roberta [9]. ABTS+• was produced by reacting 5.0 mL of 7.0 mM aqueous ABTS+• solution with 88.0 μL of 140 mM potassium persulfate in the dark at room temperature for 12 to 16 h and was used within 2 days. The ABTS+• solution was diluted with phosphate buffer (0.01 mol/L, pH 7.4) to an absorbance of 0.70 ± 0.02 at 734 nm. 0.1 mL of diluted sample was mixed with 3.9mL of diluted ABTS•+ solution. The mixture was then allowed to stand for 6 min at room temperature, and the absorbance was immediately recorded at 734 nm. The percentage of scavenged ABTS•+ was calculated as: scavenging rate (%) = [1-A1/A0]×100, where A1 is the absorbance of the solution including 0.1 mL of diluted sample and 3.9 mL of diluted ABTS•+ solution, A0 is the absorbance of the reaction solution with sample replaced by equal volume of phosphate buffer. The IC50 value was defined as the concentration of sample (mg/mL) required to scavenge 50% of ABTS radical. Ascorbic acid was used as a positive control. All experiments were carried out in triplicate.
The reducing power was determined according to the procedure described by Gu [10] with minor modifications. Briefly, the sample with various concentrations (1.0 mL) was mixed with 1.0 mL of phosphate buffer (0.2 M, pH 6.6) and 1.0 mL of potassium ferricyanide (1%, w/v). After incubating at 50°C for 20 min, 1.0 mL of trichloroacetic acid (10%, w/v) was added to the mixture. After vortex, the fluid was centrifuged at 3000g for 10 min. 2.0 mL of upper layer of solution were collected and mixed with 2.0 mL of distilled water and 0.4 mL of ferric chloride (0.1%, w/v). After storage at room temperature for 10 min, the absorbance was measured at 700 nm. Blank sample included neither sample nor ferric chloride. Higher absorbance indicated greater reductive potential. The synthetic antioxidant ascorbic acid was used as a positive control. All experiments were carried out in triplicate.
All the tests were carried out in triplicate. The experimental data were presented as means ± standard deviations (SD). The statistical analysis was performed using one-way analysis of variance (ANOVA) and Origin_8.0. The significant difference was determined with 95% confidence interval (P < 0.05).
Protein hydrolysates obtained after hydrolysis of proteins are composed of free amino acids and short chain peptides exhibiting many advantages as nutraceuticals or functional foods because of their amino acid profile. The amino acid composition of any food proteins plays a significant role in various physiological activities of human body and affects good health directly or indirectly. Amino acids are essential for synthesis of a wide variety of proteins with important functions including carriers of oxygen, vitamins, CO2, enzymes and structural proteins [11]. The amino acid compositions of fish protein hydrolysates are important because of the nutritional value and the influence on the functional properties [12]. The amino acid compositions of oyster enzymatic hydrolysates and oyster muscle are shown in Table 1.
Amino Acid | Quality composition (mg/g) | |
Oyster Muscle | Enzymatic Hydrolysate | |
Aspartic acid (Asp) |
67.70 | 41.52 |
Serine (Ser) |
42.72 | 79.80 |
Glutamic acid (Glu) |
100.12 | 93.53 |
Glycine (Gly) |
62.45 | 41.94 |
Histidine (His) |
143.83 | 95.14 |
Arginine (Arg) |
22.20 | 27.16 |
Threonine (Thr)* |
74.87 | 118.27 |
Alanine (Ala) |
28.34 | 42.14 |
Alanine (Ala) |
28.34 | 42.14 |
Proline (Pro) |
49.65 | 39.93 |
Cysteine (Cys) |
70.40 | 20.93 |
Tyrosine (Tyr) |
53.40 | 60.51 |
Valine (Val)* |
48.35 | 62.49 |
Methionine (Met)* |
26.93 | 29.52 |
Lysine (Lys)* |
49.00 | 76.47 |
Isoleucine (Ile)* |
37.50 | 59.91 |
Leucine (Leu)* |
67.82 | 89.17 |
Phenylalanine (Phe) |
53.48 | 21.10 |
The volatile flavor components of oyster enzymatic hydrolysates extracted by ether were detected using GC-MS and analyzed both qualitatively and quantitatively. Compounds were identified by comparison with the mass spectra in the electron impact mode. Table 2
Number | Retention time/min | Compound | Relative content/% |
1 | 4.56 | Isoamyl butyrate | 0.91 |
2 | 5.38 | Lauric acid | 0.50 |
3 | 5.87 | 3-Ethyl-3-methylheptane | 0.52 |
4 | 6.39 | 3-Ethyl-3-methylheptane | 0.52 |
5 | 6.72 | Hexaldehyde | 1.27 |
6 | 6.85 | 2-Octanone | 0.34 |
7 | 7.38 | Paraxylene | 1.79 |
8 | 7.53 | 2,2-Dimethyl-1-octanol | 0.61 |
9 | 7.72 | Benzaldehyde | 1.45 |
10 | 7.87 | Methyl pentadecanoate | 0.62 |
11 | 8.21 | Benzyl alcohol | 0.90 |
12 | 9.65 | Hexylenic aldehyde | 0.30 |
13 | 9.81 | Methyl-cyclohexanol | 0.37 |
14 | 10.15 | 4-Hydroxy-benzeneethanol | 0.46 |
15 | 11.45 | Methyl hexadecanoate | 1.55 |
16 | 11.90 | 1-Octene-3-ol | 0.61 |
17 | 12.78 | (E, E) -2,4- Heptadienal | 1.53 |
18 | 13.45 | Cyclohexyl methyl sulphide | 0.19 |
19 | 14.80 | Trans -2- decent aldehyde | 0.99 |
20 | 15.89 | 2,3- Pentanedione | 0.17 |
21 | 16.54 | Nonaldehyde | 2.97 |
22 | 16.81 | 4-Ethyl-4-heptanol | 0.19 |
23 | 19.57 | Trans-2, cis -6- nonadienal | 0.93 |
24 | 25.35 | 2-Undecanone | 0.07 |
25 | 25.78 | Hexadecanoic acid methyl ester | 2.37 |
26 | 26.82 | n-Hexadecanoic acid | 1.21 |
27 | 27.68 | Phthalate | 0.84 |
28 | 28.39 | Glycinamide | 0.97 |
29 | 33.50 | Phenol,2,2’-Methylenebis[6-(1,1- dimethyl-ethyl)-4-methyl- | 2.93 |
30 | 35.48 | Stearic Acid | 0.62 |
31 | 39.82 | 4,4-Dimethyl-undecane | 0.11 |
32 | 40.12 | Diisobutyl phthalate | 0.45 |
33 | 40.27 | Isopropyl palmitate | 1.03 |
34 | 44.31 | Cyclohexylamine | 0.46 |
Radicals DPPH is a stable free radical that shows maximum absorption at 517 nm in ethanol. When DPPH encounters a proton-donating substance (H+), the radical is scavenged by changing color from purple to yellow and the absorbance is reduced [17].


It is well known that hydroxyl radical is extremely reactive and damages adjacent biomolecules such as protein, fatty acids, DNA and nucleic acids [19]. Therefore, hydroxyl free radical is deemed to be the typical representative among all free radicals, and is widely used to monitor and evaluate the antioxidant ability of protein hydrolysates [20]. The hydroxyl radical scavenging activities of oyster enzymatic hydrolysates and ascorbic acid are presented in Figure 1 and Figure 2, respectively. The oyster enzymatic hydrolysates were found to have the ability of scavenging hydroxyl radicals. The scavenging effects of oyster enzymatic hydrolysates were gradually increased with increasing concentration. The oyster enzymatic hydrolysates may scavenge hydroxyl radicals by electron/hydrogen donation and radical quenching [21]. The IC50 value for the oyster enzymatic hydrolysates was 6.43 mg/mL, which is lower than ascorbic acid (IC50= 38.90 μg/mL).
The scavenging effect of oyster enzymatic hydrolysates on ABTS radicals was measured, and the results are shown in Figure 3. The scavenging activity of enzymatic hydrolysates toward ABTS radicals was related to oyster enzymatic hydrolysates concentrations, the results indicated that oyster enzymatic hydrolysates could effectively scavenge ABTS radicals in a dose-dependent way at the concentrations increasing from 0.5 to 2.5 mg/mL. The IC50 value of the oyster enzymatic hydrolysates was 0.86 mg/mL for ABTS radical scavenging activity. It was higher than those of other protein hydrolysates reported [22]. As shown in Figure 4, the positive control as ascorbic acid showed more potent scavenging activity and its IC50 value was 26.95 μg/ML.
The reducing power assay is often used to evaluate the ability of an antioxidant to donate electrons [23]. The reducing power of oyster enzymatic hydrolysates was measured by transformation of Fe3+ to Fe2+. Figure3 shows the reducing power, expressed as absorbance at 700 nm, of oyster enzymatic hydrolysates. The oyster enzymatic hydrolysates showed reductive capabilities in a dose dependent manner and the maximum reducing power was found at 0.698 ± 0.02 in 2.5 mg/mL and the minimum reducing power was found at 0.165 ± 0.017 in 0.5 mg/mL. The oyster enzymatic hydrolysates had the strongest reducing power with an IC50 value of 1.52 mg/mL. Although the reducing power of oyster enzymatic hydrolysates was lower than that of ascorbic acid (IC50= 13.84 μg/mL), it was higher than the oyster protein hydrolysates reported by Dong [24]. Hence, from the results, it appears that the oyster enzymatic hydrolysates could be excellent electron donors to free radicals.


Using gel permeation chromatography (GPC) to determinate the number average molecular weight (Mn) of oyster enzymatic hydrolysates. The results are shown in Table 3 and Figure 5.
Peak | Mn | Mw | Mp | Mz | Mz+1 |
1 | 10134 | 12978 | 9022 | 17788 | 23944 |
2 | 324 | 338 | 327 | 354 | 372 |
3 | 109 | 112 | 110 | 114 | 116 |

- Dong SY., et al. “Antioxidant and biochemical properties of protein hydrolysates prepared from Silver carp (Hypophthalmichthys molitrix”. Food Chemistry 107.4 (2008): 1485-1493.
- NS Hettiarachchy., et al. “Natural antioxidant extract from fenugreek (Trigonella foenumgraecum) for ground beef patties”. Journal of Food Science 61.3 (1996): 516-519.
- Li XX., et al. “In vitro antioxidant activity of protein hydrolysates prepared from corn gluten meal”. Journal of the Science of Food and Agriculture 88.9 (2008): 1660-1666.
- Chi CF., et al. “Isolation and characterization of three antioxidant peptides from protein hydrolysate of bluefin leatherjacket (Navodon septentrionalis) heads”. Journal of Functional Foods 12 (2015): 1-10.
- Liu Y., et al. “Study on enzymatic hydrolysis technology of oyster meat by ficin and its antioxidant activity”. Science and Technology of Food Industry 36.18 (2015): 182-185,192.
- Arumugam S., et al. “Purification and characterization of antioxidant peptides from oyster (Saccostrea cucullata) hydrolysate and the anticancer activity of hydrolysate on human colon cancer cell lines”. International Journal of Peptide Research and Therapeutics 20.2 (2013): 231-243.
- Wu YY., et al. “Application of response surface methodology to optimise preparation high antioxidant activity product from Pinctada Fucata Muscle”. Advanced Materials Research 396-398 (2012): 1341-1348.
- Wang H., et al. “In vitro and in vivo antioxidant activity of aqueous extract from Choerospondias axillaris fruit”. Food Chemistry 106.3 (2008): 888-895.
- Roberta R., et al. “Antioxidant activity applying an improved ABTS radical cation decolorization assay”. Free Radical Biology and Medicine 26.9-10 (1999): 1231-1237.
- Gu M., et al.“Isolation and identification of antioxidative peptides from frog (Hylarana guentheri) protein hydrolysate by consecutive chromatography and electrospray ionization mass spectrometry”. Applied Biochemistry and Biotechnology 173.5 (2014): 1169-1182.
- M Chalamaiah., et al. “Fish protein hydrolysates: Proximate composition, amino acid composition, antioxidant activities and applications: A review”. Food Chemistry 135.4 (2012): 3020-3038.
- Sarita DS., et al. “Evaluation of functional properties in protein hydrolysates from Bluewing Searobin (Prionotus punctatus) obtained with different microbial enzymes”. Food and Bioprocess Technology 4.8 (2011): 1399-1406.
- Zhu LJ., et al. “Reducing, radical scavenging, and chelation properties of in vitro digests of alcalase-treated zein hydrolysate”. Journal of Agricultural and Food Chemistry 56.8 (2008): 2714-2721.
- Peng Y., et al “Health care function of arginine with its regulation”. Journal of Hunan Institute of Science and Technology (Natural Sciences) 24.1 (2011): 59-62.
- Je JY., et al. “Amino acid changes in fermented oyster (Crassostrea gigas) sauce with different fermentation periods”. Food Chemistry 91.1 (2005): 15-18.
- David BJ., et al. “Volatile compounds characterizing the aroma of fresh Atlantic and pacific oysters”. Journal of Food Science 50.1 (1985): 5-9.
- Liu Q., et al. “Antioxidant activity and functional properties of porcine plasma protein hydrolysate as influenced by the degree of hydrolysis”. Food Chemistry 118.2 (2010): 403-410.
- KH Sabeena., et al. “Antioxidant activity of Cod (Gadus morhua) protein hydrolysates: In vitro assays and evaluation in 5% fish oil-in-water emulsion”. Food Chemistry 149.15 (2014): 326-334.
- Okezie I., et al. “Free radicals, oxidative stress, and antioxidants in human health and disease”. Journal of the American Oil Chemists’ Society 75.2 (1998): 199-212.
- Kim EK., et al. “Purification of a novel peptide derived from Mytilus coruscus and in vitro/in vivo evaluation of its bioactive properties”. Fish and Shellfish Immunology 34.5 (2013): 1078-1084.
- Kong BH., et al. “Antioxidant activity of zein hydrolysates in a liposome system and the possible mode of Action”. Journal of Agricultural and Food Chemistry 54.16 (2006): 6059-6068.
- Ahn CB., et al. “Purification and antioxidant properties of octapeptide from salmon by-product protein hydrolysate by gastrointestinal digestion”. Food Chemistry 147.15 (2014): 78-83.
- Ali Y., et al. “Comparison of antioxidant and antimicrobial activities of tilia (Tilia argentea Desf ExDC), sage (Salviat riloba L.), and black tea (Camellia sinensis) extracts”. Journal of Agricultural and Food Chemistry 48.10 (2000): 5030-5034.
- Dong XP., et al. “Preparation and in vitro antioxidant activity of enzymatic hydrolysates from oyster (Crassostrea talienwhannensis) meat”. International Journal of Food Science and Technology 45.5 (2010): 978-984.
- Power O., et al. “FitzGerald Antioxidative peptides: enzymatic production, in vitro and in vivo antioxidant activity and potential applications of milk-derived antioxidative peptides”. Amino Acids 44.3 (2013): 797-820.
- Nune S S K., et al. “In vivo antioxidant activity of peptide purified from viscera protein hydrolysate of horse mackerel (Magalaspis cordyla)”. International Journal of Food Science and Technology 47.7(2012): 1558-1562.
Journal Menu
PubMed Indexed Article
EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.
PMID: 31143884 [PubMed]
PMCID: PMC6536005
EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.
PMID: 31565701 [PubMed]
PMCID: PMC6764777
EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.
PMID: 27747317 [PubMed]
PMCID: PMC5065347
EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?
PMID: 31460519 [PubMed]
PMCID: PMC6711478
EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?
PMID: 30215059 [PubMed]
PMCID: PMC6133253
EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.
PMID: 30417173 [PubMed]
PMCID: PMC6226033
EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.
PMID: 30264037 [PubMed]
PMCID: PMC6155992
EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.
PMID: 30198026 [PubMed]
PMCID: PMC6124505
EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.
PMID: 30294723 [PubMed]
PMCID: PMC6169793
EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs
PMID: 29285526 [PubMed]
PMCID: PMC5743211
EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique
PMID: 29911204 [PubMed]
PMCID: PMC5999047
EC Microbiology
Macrophages and the Viral Dissemination Super Highway
PMID: 26949751 [PubMed]
PMCID: PMC4774560
EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.
PMID: 27390782 [PubMed]
PMCID: PMC4933318
EC Microbiology
Reactive Oxygen Species in HIV Infection
PMID: 28580453 [PubMed]
PMCID: PMC5450819
EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population
PMID: 26280024 [PubMed]
PMCID: PMC4533840
EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis
PMID: 28066845 [PubMed]
PMCID: PMC5214344
EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology
PMID: 28936490 [PubMed]
PMCID: PMC5604476
EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia
PMID: 28713879 [PubMed]
PMCID: PMC5510658
EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature
PMID: 28133641 [PubMed]
PMCID: PMC5267489
EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling
PMID: 29333536 [PubMed]
PMCID: PMC5766278
EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.
PMID: 31032493 [PubMed]
PMCID: PMC6483108
EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.
PMID: 30957099 [PubMed]
PMCID: PMC6448571
EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.
PMID: 30101228 [PubMed]
PMCID: PMC6086333
EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.
PMID: 31080964 [PubMed]
PMCID: PMC6508883
EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.
PMID: 31093608 [PubMed]
PMCID: PMC6513001
EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.
PMID: 31552397 [PubMed]
PMCID: PMC6758937
EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.
PMID: 31681909 [PubMed]
PMCID: PMC6824723
EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.
PMID: 31681910 [PubMed]
PMCID: PMC6824726
EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.
PMID: 31528859 [PubMed]
PMCID: PMC6746603
EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?
PMID: 31276119 [PubMed]
PMCID: PMC6604646
EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.
PMID: 31406965 [PubMed]
PMCID: PMC6690616
EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.
PMID: 31517314 [PubMed]
PMCID: PMC6741290
EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.
PMID: 31633124 [PubMed]
PMCID: PMC6800226
EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.
PMID: 29662969 [PubMed]
PMCID: PMC5898812
EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.
PMID: 30215058 [PubMed]
PMCID: PMC6133268
News and Events
February Issue Release
We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the February issue of respective journals and the latest articles can be viewed on the current issue pages.
Submission Deadline for Upcoming Issue
ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 21, 2023.
Certificate of Publication
ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.
Best Article of the Issue
Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.
Certifying for Review
ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.
Latest Articles
The latest articles will be updated immediately on the articles in press page of the respective journals.